fenofibrate has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage of 1-methyl-4-phenyl pyridinium (MPP+) in the striatum by high-performance liquid chromatography indicated that fenofibrate did not affect MPTP metabolism." | 1.34 | Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not. ( Bordet, R; Destée, A; Gelé, P; Kreisler, A; Lhermitte, M; Wiart, JF, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbiero, JK | 2 |
| Santiago, R | 1 |
| Tonin, FS | 2 |
| Boschen, S | 1 |
| da Silva, LM | 1 |
| Werner, MF | 1 |
| da Cunha, C | 2 |
| Lima, MM | 2 |
| Vital, MA | 2 |
| Santiago, RM | 1 |
| Persike, DS | 1 |
| da Silva Fernandes, MJ | 1 |
| Lucio Boschen, S | 1 |
| Kreisler, A | 1 |
| Gelé, P | 1 |
| Wiart, JF | 1 |
| Lhermitte, M | 1 |
| Destée, A | 1 |
| Bordet, R | 1 |
3 other studies available for fenofibrate and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
Topics: Animals; Avoidance Learning; Corpus Striatum; Disease Models, Animal; Dopamine; Encephalitis; Explor | 2014 |
Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine.
Topics: Animals; Avoidance Learning; Caspase 3; Disease Models, Animal; Dopamine; Drug Administration Schedu | 2014 |
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acyl Coenzyme A; Analysis of Variance; Animals; Bezafi | 2007 |